首页> 外文OA文献 >Purification of biomimetic apatite-based hybrid colloids intended for biomedical applications: a dialysis study
【2h】

Purification of biomimetic apatite-based hybrid colloids intended for biomedical applications: a dialysis study

机译:拟用于生物医学应用的仿生磷灰石基杂化胶体的纯化:一项透析研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The field of nanobiotechnology has lately attracted much attention both from therapeutic and diagnosisudviewpoints. Of particular relevance is the development of colloidal formulations of biocompatible nanoparticles capable of interacting with selected cells or tissues. In this context, the purification of such nanoparticle suspensions appears as a critical step as residues of unreacted species may jeopardize biological and medical outcomes, and sample purity is thus increasingly taken into account by regulatory committees. In the present work, we have investigated from a physico-chemical point of view the purification by dialysis of recently developed hybrid colloids based on biomimetic nanocrystalline apatitesudintended for interacting with cells. Both Eu-doped (2 mol.% relative to Ca) and Eu-free suspensions were studied. The follow-up of the dialysis process was carried out by way of FTIR, TEM, XRD, pH and conductivity measurements. Mathematical modelling of conductivity data was reported. The effects of a change in temperature (25 and 45 ◦C), dialysis medium, and starting colloid composition were evaluated and discussed. We show that the dialysis method is a well-adapted and cheap technique to purify such mineral–organic hybrid suspensions in view of biomedical applications, and we point out some of the characterization techniques that may prove helpful for following the evolution of the purification process with time.
机译:从治疗和诊断的角度来看,纳米生物技术领域近来引起了很多关注。特别相关的是能够与选定的细胞或组织相互作用的生物相容性纳米粒子的胶体制剂的开发。在这种情况下,此类纳米颗粒悬浮液的纯化似乎是关键步骤,因为未反应物种的残留物可能会危害生物学和医学成果,因此监管委员会越来越多地考虑样品纯度。在目前的工作中,我们从物理化学的角度研究了通过透析纯化的基于仿生纳米晶磷灰石的新型混合胶体的纯化方法,该混合体被认为与细胞相互作用。研究了掺Eu(相对于Ca为2摩尔%)和不含Eu的悬浮液。透析过程的后续过程通过FTIR,TEM,XRD,pH和电导率测量进行。报告了电导率数据的数学模型。评估并讨论了温度变化(25和45℃),透析介质和起始胶体组成的影响。我们表明,鉴于生物医学应用,透析方法是一种纯化此类矿物-有机杂化悬浮液的适应性强且廉价的技术,并且我们指出了一些表征技术可能对跟踪纯化过程的发展有帮助。时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号